Observed situation in France for the week 03 of the year 2026, from 01/12/2026 to 01/18/2026 :
Published on 01-21-2026 16:01 - These news are updated on wednesday
Acute Respiratory Infection (ARI) Covid-19, Influenza and other respiratory viruses Définition
Moderate activity in general practice
Previously on sentiweb
In mainland France, last week (2026w03), the incidence rate of acute respiratory infection (ARI) cases consulting in general practice was estimated at 359 cases per 100,000 population (95% CI [347; 371]).
Subject to future data consolidation, this rate is increasing for the third consecutive week and corresponds to a similar level of activity than those usually observed at this time of the year (consolidated data for 2026w02: 317 [307; 328]).
At the regional level, the highest incidence rates were noted in: Bretagne (545 [483; 607]), Nouvelle-Aquitaine (509 [458; 559]) and Corse (432 [313; 551]).
Influenza: the incidence rate of influenza cases seen in general practice for an ARI was estimated at 167 cases per 100,000 population (95% CI [142; 192]), corresponding to 112,539 [95,671; 129,407] new cases (data sources: Sentinelles, SOS Médecins, DMGs Côte d’Azur, Rouen and Strasbourg).
Subject to future data consolidation, this rate is stable (consolidated data for 2026w02: 156 [134; 178]) and corresponds to a moderate level of activity. By age group, we note however an increase in children (0-14 ans).
RSV infection: the incidence rate of RSV infection cases seen in general practice for an ARI was estimated at 46 cases per 100,000 population (95% CI [34; 58]), corresponding to 31,239 [23,200; 39,278] new cases (data sources: Sentinelles, SOS Médecins, DMGs Côte d’Azur, Rouen and Strasbourg).
Subject to future data consolidation, this rate is slightly increasing (consolidated data for 2026w02: 36 [26; 45]) and corresponds to a high level of activity, in particular among adults (15 years and above).
Bronchiolitis in children under one year old : the incidence rate of bronchiolitis cases in children under one year old seen in general practice was estimated at 341 cases per 100,000 population (95% CI [153; 529]) (data source: IQVIA (EMR)).
Subject to future data consolidation, this rate is stable (consolidated data for 2026w02: 440 [215; 665]) and corresponds to a low level of activity.
Covid-19: the incidence rate of Covid-19 cases seen in general practice for an ARI was estimated at 3 cases per 100,000 population (95% CI [2; 5]), corresponding to 2,223 [1,330; 3,116] new cases (data source: Sentinelles).
Subject to future data consolidation, this rate is stable (consolidated data for 2026w02: 5 [4; 7]) and corresponds to a low level of activity.
| Estimated weekly incidence rate | Estimated weekly incidence | |
|---|---|---|
| France | 359 [347 ; 371] | 241557 [233583 ; 249531] |
| Regions | ||
| Grand Est | 385 [344 ; 427] | 21807 [19456 ; 24158] |
| Nouvelle-Aquitaine | 509 [458 ; 559] | 31993 [28818 ; 35168] |
| Auvergne-Rhône-Alpes | 397 [360 ; 433] | 33211 [30126 ; 36296] |
| Bourgogne-Franche-Comté | 394 [334 ; 453] | 11313 [9603 ; 13023] |
| Bretagne | 545 [483 ; 607] | 19283 [17099 ; 21467] |
| Centre-Val de Loire | 233 [186 ; 281] | 6165 [4905 ; 7425] |
| Corse | 432 [313 ; 551] | 1557 [1128 ; 1986] |
| Ile-de-France | 218 [196 ; 239] | 27368 [24689 ; 30047] |
| Occitanie | 374 [331 ; 417] | 23357 [20650 ; 26064] |
| Hauts-de-France | 321 [282 ; 359] | 19497 [17167 ; 21827] |
| Normandie | 313 [265 ; 361] | 10689 [9047 ; 12331] |
| Pays de la Loire | 306 [249 ; 363] | 12232 [9938 ; 14526] |
| Provence-Alpes-Côte d'Azur | 422 [372 ; 472] | 22347 [19710 ; 24984] |
Table showing incidence and incidence rate for the geographic area of the information bloc and eventually for the geographic sub-levels
Acute diarrhea Définition
Low activity in general practice
Previously on sentiweb
In mainland France, last week (2026w03), the incidence rate of acute diarrhea cases seen in general practice was estimated at 89 cases per 100,000 population (95% CI [83; 95]).
Subject to future data consolidation, this rate is increasing compared to the previous week but corresponds to a lower level of activity than those usually observed at this time of the year (consolidated data for 2026w02: 75 [69; 80]).
At the regional level, the highest incidence rates were noted in: Nouvelle-Aquitaine (146 [118; 175]), Provence-Alpes-Côte d’Azur (142 [114; 171]) and Bretagne (138 [107; 170]).
Data sources: Sentinelles and IQVIA (EMR)
| Estimated weekly incidence rate | Estimated weekly incidence | |
|---|---|---|
| France | 89 [83 ; 95] | 60117 [56105 ; 64129] |
| Regions | ||
| Grand Est | 89 [69 ; 109] | 5065 [3930 ; 6200] |
| Nouvelle-Aquitaine | 146 [118 ; 175] | 9201 [7418 ; 10984] |
| Auvergne-Rhône-Alpes | 55 [41 ; 69] | 4598 [3450 ; 5746] |
| Bourgogne-Franche-Comté | 58 [36 ; 81] | 1675 [1027 ; 2323] |
| Bretagne | 138 [107 ; 170] | 4892 [3775 ; 6009] |
| Centre-Val de Loire | 52 [31 ; 74] | 1386 [807 ; 1965] |
| Corse | 43 [5 ; 80] | 154 [19 ; 289] |
| Ile-de-France | 52 [41 ; 62] | 6492 [5198 ; 7786] |
| Occitanie | 128 [102 ; 154] | 8013 [6402 ; 9624] |
| Hauts-de-France | 113 [90 ; 135] | 6850 [5496 ; 8204] |
| Normandie | 44 [26 ; 62] | 1516 [900 ; 2132] |
| Pays de la Loire | 61 [36 ; 87] | 2447 [1427 ; 3467] |
| Provence-Alpes-Côte d'Azur | 142 [114 ; 171] | 7529 [6019 ; 9039] |
Table showing incidence and incidence rate for the geographic area of the information bloc and eventually for the geographic sub-levels
Subject to future data consolidation, this rate is slightly decreasing for two weeks and corresponds to a lower level of activity than those usually observed at this time of the year (consolidated data for 2026w02: 9 [7; 11]).
At the regional level, the highest incidence rates were noted in: Corse (15 [0; 37]), Pays de la Loire (10 [0; 22]) and Ile-de-France (9 [5; 13]).
Data sources: Sentinelles and IQVIA (EMR)
| Estimated weekly incidence rate | Estimated weekly incidence | |
|---|---|---|
| France | 6 [4 ; 7] | 4004 [2983 ; 5025] |
| Regions | ||
| Grand Est | 5 [1 ; 10] | 297 [40 ; 554] |
| Nouvelle-Aquitaine | 6 [1 ; 10] | 347 [55 ; 639] |
| Auvergne-Rhône-Alpes | 5 [2 ; 9] | 450 [130 ; 770] |
| Bourgogne-Franche-Comté | 6 [0 ; 13] | 169 [0 ; 381] |
| Bretagne | 1 [0 ; 2] | 24 [0 ; 71] |
| Centre-Val de Loire | 5 [0 ; 11] | 119 [0 ; 289] |
| Corse | 15 [0 ; 37] | 54 [0 ; 135] |
| Ile-de-France | 9 [5 ; 13] | 1132 [580 ; 1684] |
| Occitanie | 2 [0 ; 5] | 129 [0 ; 312] |
| Hauts-de-France | 4 [0 ; 8] | 221 [0 ; 464] |
| Normandie | 4 [0 ; 10] | 151 [0 ; 327] |
| Pays de la Loire | 10 [0 ; 22] | 417 [0 ; 862] |
| Provence-Alpes-Côte d'Azur | 7 [0 ; 14] | 382 [25 ; 739] |
Table showing incidence and incidence rate for the geographic area of the information bloc and eventually for the geographic sub-levels
Surveillance of acute respiratory infections by the Sentinelles network (Covid-19, influenza and RSV infections)
In March 2020, following the emergence of SARS-CoV-2 (COVID-19), the “Sentinelles surveillance” evolved. The surveillance of “influenza-like illness” (ILI, defined as sudden onset of fever above 39°C, accompanied by myalgia and respiratory signs) has been replaced by “acute respiratory infections” (ARI, defined as sudden onset of fever or feeling of fever and respiratory signs).
This new surveillance enables both the monitoring of the COVID-19 pandemic and epidemics due to other respiratory viruses (influenza, respiratory syncytial virus (RSV), rhinovirus and metapneumovirus). This surveillance is carried out with “Santé publique France” (the national agency for public health), the National Reference Center for respiratory infections (“Institut Pasteur” and “Hospices Civils de Lyon”) and the University of Corsica. This surveillance is based on patients consulting a general practitioner or a paediatrician for an ARI.
Data from the Sentinelles network are integrated into the overall national COVID-19 surveillance coordinated by “Santé publique France”. For more information, you can consult the weekly COVID-19 and influenza newsletters from “Santé publique France”.
At the same time, the Sentinelles network is carrying out studies and research on Covid-19, which are presented in the “Covid-19” section of this website.
